CVS Health Corporation (CVS)

NYSE · Woonsocket, Rhode Island, USA · Founded 1963 · CEO David Joyner

Valuation summary

$215.58 fair value versus $80.04 in the market, a difference of +169.3%. Rated Strong Buy.

Fair value per share$215.58
Current share price$80.04
Upside / downside+169.3%
Bear case$69.12
Bull case$448.66
Discount rate (WACC)9.4%
Terminal growth2.40%
Market capitalisation$102B
EV / Sales0.4x

About CVS Health Corporation

Founded in 1963 as Consumer Value Stores. David Joyner became CEO in October 2024 after a period of severe underperformance. CVS is unusually vertically integrated: it owns retail pharmacies, Caremark (a large pharmacy benefit manager), and Aetna (a major health insurer). The theory is that owning the whole chain lowers costs; the practice has been that problems in any one part drag down the whole.

Investment case

  • Vertical integration across pharmacy, benefits management and insurance is genuinely difficult to replicate.
  • Around 9,000 retail locations put a pharmacy within reach of most of the US population.
  • Valuation is depressed enough that modest operational improvement could re-rate the shares.

Key risks

  • Medicare Advantage utilisation ran far above expectations, causing repeated guidance cuts, and management still describes cost trends as elevated.
  • Retail pharmacy faces structural pressure from mail order and Amazon.
  • Very heavy debt load following the Aetna acquisition constrains flexibility.

Recent developments

Revenue by segment

Health Services (Caremark)47%
Health Care Benefits (Aetna)33%
Pharmacy & Consumer Wellness20%

Five-year forecast

RevenueFree cash flow
Year 1$444.7B$14.5B
Year 2$474.7B$16.5B
Year 3$506.6B$18.7B
Year 4$540.7B$21.1B
Year 5$577.1B$23.8B

What the street says

A turnaround that is now showing results: in August 2026 CVS raised full-year adjusted EPS guidance to $7.90-$8.10, crediting the Aetna margin recovery plan. Management kept a cautious stance for the rest of the year because of elevated cost trends, so the durability of the Medicare Advantage margin recovery remains the key variable.

Comparable companies: CI · HCA · ELV · COR · MCK · MDLN · IQV · GEHC

Open the interactive model, price chart and sensitivity grid →